BlackRock Advisors’s Regenxbio RGNX Stock Holding History

BlackRock Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$13.2M	Buy	709,444 +15,536	+2%	+$297K	0.01%	749
2016 Q3	$9.72M	Buy	693,908 +6,251	+0.9%	+$69K	0.01%	871
2016 Q2	$5.5M	Buy	687,657 +685,149	+27,319%	+$7.6M	0.01%	1065
2016 Q1	$27K	Hold	2,508	–	–	﹤0.01%	3362
2015 Q4	$42K	Buy	+2,508	New	+$49.8K	﹤0.01%	3264

Other funds holding RGNX

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock Advisors's RGNX Position: Q4 2016 in Review

BlackRock Advisors increased its Regenxbio (RGNX) stake by 2.2% in Q4 2016, buying an estimated $297K and bringing the position to 709,444 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #749.

BlackRock Advisors first reported a position in RGNX in Q4 2015 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

BlackRock Advisors held 709,444 shares of Regenxbio worth $13.2M as of Q4 2016.
BlackRock Advisors bought 15,536 Regenxbio shares in Q4 2016, an estimated $297K.
Regenxbio made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #749 holding.
BlackRock Advisors first reported a position in Regenxbio in Q4 2015 and has held it in 5 quarters since.
78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.